Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Toxic optic neuropathy.

Anat Kesler1, Pazit Pianka

  • 1Neuro-Ophthalmology Unit, Department of Ophthalmology, Tel Aviv Medical Center, 6 Weizmann Street, Tel Aviv 64239, Israel. kesler@netvision.net.il

Current Neurology and Neuroscience Reports
|August 14, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A case of a young patient with progressive vision loss: An atypical presentation of the rare Wolfram Syndrome in a Middle Eastern individual.

American journal of ophthalmology case reports·2025
Same author

A genetic survey of patients with familial idiopathic intracranial hypertension residing in a Middle Eastern village: genetic association study.

European journal of medical research·2024
Same author

Neovascular Glaucoma as a Presenting Sign of Catastrophic Antiphospholipid Syndrome with a "Catastrophic" Heart Valve Finding.

Case reports in ophthalmology·2021
Same author

"More Guts Than Brains?"-The Role of Gut Microbiota in Idiopathic Intracranial Hypertension.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2021
Same author

Papilledema and Cerebral Venous Sinus Thrombosis Due to JAK2 Mutation.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2021
Same author

The Usefulness of the Erythrocyte Sedimentation Rate and C-reactive Protein for the Differential Diagnosis of Non-Arteritic Anterior Ischemic Optic Neuropathy in the Era of Microinflammation.

Ocular immunology and inflammation·2020
Same journal

The Noradrenergic Brain in Parkinson's Disease.

Current neurology and neuroscience reports·2026
Same journal

Mapping the Silent Onset of Parkinson's Disease: Monoamine Imaging in the Era of the Race for Preclinical Intervention.

Current neurology and neuroscience reports·2026
Same journal

Functional and Structural Brain Imaging Correlates of Treatment Response in Functional Movement Disorder.

Current neurology and neuroscience reports·2026
Same journal

Astrocytopathy in Wernicke Encephalopathy and Neuromyelitis Optica Spectrum Disorder. Pathogenic Differences With Occasional Clinical and Neuroimaging Overlap. A Review.

Current neurology and neuroscience reports·2026
Same journal

When is the Radiologically Isolated Syndrome already Multiple Sclerosis According to the 2024 McDonald Criteria?

Current neurology and neuroscience reports·2026
Same journal

Assessment and Management of Post-traumatic Headache.

Current neurology and neuroscience reports·2026
See all related articles

Toxic optic neuropathy, a multifactorial vision disorder, causes progressive, painless vision loss. Early detection and management are crucial for preventing severe visual deficits.

Area of Science:

  • Ophthalmology
  • Neurology
  • Toxicology

Background:

  • Toxic optic neuropathy is a complex condition with diverse causes, including nutritional, environmental, toxicologic, and genetic factors.
  • While nutritional amblyopia is more prevalent in developing nations, toxic optic neuropathy from alcohol or drug abuse affects Western populations.
  • This condition typically presents as progressive, bilateral, symmetrical, and painless vision loss with central or cecocentral scotoma.

Purpose of the Study:

  • To review the multifactorial etiology of toxic optic neuropathy.
  • To describe the typical clinical presentation and progression of the disease.
  • To emphasize the importance of early detection and management in mitigating visual impairment.

Main Methods:

  • Literature review of toxic optic neuropathy.

Related Experiment Videos

  • Analysis of etiological factors.
  • Clinical case review (implied).

    • Main Results:

    • Identified nutritional, environmental, toxicologic, and genetic factors as key etiologies.
    • Highlighted the prevalence of nutritional amblyopia in disadvantaged regions and toxic amblyopia in Western countries.
    • Described characteristic symptoms: progressive, bilateral, symmetrical, painless vision loss with central/cecocentral scotoma.

    Conclusions:

    • Toxic optic neuropathy is a complex disease with varied origins.
    • There is no specific cure, but early diagnosis and prompt intervention can significantly improve outcomes and prevent irreversible vision loss.